Efficiency of interferon inductor anaferon (pediatric formulation) in prophylaxis of acute respiratory infections in sickly children

Bull Exp Biol Med. 2009 Aug;148(2):270-4. doi: 10.1007/s10517-009-0705-x.

Abstract

Prophylactic efficiency and safety of anaferon (pediatric formulation) in children aging 1?month to 4 years, including sickly children, was proven. The use of the preparation in children reduced the incidence of acute respiratory infections, alleviated the course of the disease, and decreased the incidence of detection of viral antigens in nasal meatuses.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Antibodies / therapeutic use*
  • Antiviral Agents / therapeutic use*
  • Child, Preschool
  • Humans
  • Infant
  • Interferon Inducers / therapeutic use*
  • Interferon-gamma / metabolism
  • Respiratory Tract Infections / drug therapy*
  • Respiratory Tract Infections / prevention & control*
  • Respiratory Tract Infections / virology
  • Treatment Outcome

Substances

  • Antibodies
  • Antiviral Agents
  • Interferon Inducers
  • anaferon
  • Interferon-gamma